In conclusion, our work reveals a moonlighting function of nuclear GCLM and implicates the P38 MAPK–nuclear GCLM–NF-κB axis as a prognostic and therapeutic target for CRC. This evidence concerns the gene MAPK1 and colorectal carcinoma.